DDX58 and Classic Singleton-Merten Syndrome.


Journal

Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137

Informations de publication

Date de publication:
01 2019
Historique:
received: 31 05 2018
accepted: 11 11 2018
pubmed: 24 12 2018
medline: 27 11 2019
entrez: 22 12 2018
Statut: ppublish

Résumé

Singleton-Merten syndrome manifests as dental dysplasia, glaucoma, psoriasis, aortic calcification, and skeletal abnormalities including tendon rupture and arthropathy. Pathogenic variants in IFIH1 have previously been associated with the classic Singleton-Merten syndrome, while variants in DDX58 has been described in association with a milder phenotype, which is suggested to have a better prognosis. We studied a family with severe, "classic" Singleton-Merten syndrome. We undertook clinical phenotyping, next-generation sequencing, and functional studies of type I interferon production in patient whole blood and assessed the type I interferon promoter activity in HEK293 cells transfected with wild-type or mutant DDX58 stimulated with Poly I:C. We demonstrate a DDX58 autosomal dominant gain-of-function mutation, with constitutive upregulation of type I interferon. DDX58 mutations may be associated with the classic features of Singleton-Merten syndrome including dental dysplasia, tendon rupture, and severe cardiac sequela.

Identifiants

pubmed: 30574673
doi: 10.1007/s10875-018-0572-1
pii: 10.1007/s10875-018-0572-1
pmc: PMC6394545
doi:

Substances chimiques

Interferon Type I 0
Receptors, Immunologic 0
RIGI protein, human EC 3.6.1.-
DEAD Box Protein 58 EC 3.6.4.13

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-80

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI106912
Pays : United States
Organisme : Department of Health
ID : TRF-2016-09-002
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : ZIA AI001220
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI111784
Pays : United States
Organisme : NIH HHS
ID : R01 OD010944
Pays : United States

Références

Cell. 2011 Oct 14;147(2):409-22
pubmed: 22000018
Br J Dermatol. 2015 Dec;173(6):1505-13
pubmed: 26284909
J Clin Invest. 2018 Jul 2;128(7):3041-3052
pubmed: 29649002
Am J Hum Genet. 2014 Jul 3;95(1):121-5
pubmed: 24995871
Am J Hum Genet. 2015 Feb 5;96(2):275-82
pubmed: 25620204
Am J Med Genet A. 2013 Feb;161A(2):360-70
pubmed: 23322711
J Allergy Clin Immunol. 2016 Dec;138(6):1752-1755
pubmed: 27554814
Nat Genet. 2014 May;46(5):503-509
pubmed: 24686847
Nature. 2014 May 1;509(7498):110-4
pubmed: 24590070
Neurology. 2018 Feb 6;90(6):289-291
pubmed: 29321238
J Interferon Cytokine Res. 2018 Apr;38(4):171-185
pubmed: 29638206
Am J Med Genet A. 2015 Feb;167A(2):296-312
pubmed: 25604658
Arthritis Rheumatol. 2017 Oct;69(10):2081-2091
pubmed: 28605144
Nature. 2011 Sep 25;479(7373):423-7
pubmed: 21947008
Nat Commun. 2017 Dec 19;8(1):2176
pubmed: 29259162
Am J Hum Genet. 2015 Feb 5;96(2):266-74
pubmed: 25620203

Auteurs

Carlos R Ferreira (CR)

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. carlos.ferreira@nih.gov.

Yanick J Crow (YJ)

Institute of Genetics and Molecular Medicine, Centre for Genomic and Experimental Medicine, The University of Edinburgh, Edinburgh, UK.
Laboratory of Neurogenetics and Neuroinflammation, Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France.

William A Gahl (WA)

Office of the Clinical Director and Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

Pamela J Gardner (PJ)

Office of the Clinical Director, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.

Raphaela Goldbach-Mansky (R)

Translational Autoinflammatory Disease Studies (TADS), National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health, Bethesda, MD, USA.

Sun Hur (S)

Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA.

Adriana Almeida de Jesús (AA)

Translational Autoinflammatory Disease Studies (TADS), National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health, Bethesda, MD, USA.

Michele Nehrebecky (M)

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

Ji Woo Park (JW)

Biology Department in Morrissey College of Arts and Sciences, Boston College, Chestnut Hill, USA.

Tracy A Briggs (TA)

Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust Manchester Academic Health Sciences Centre, Manchester, UK. Tracy.briggs@manchester.ac.uk.
Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK. Tracy.briggs@manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH